health news today obesity drugs glp-1 Chart: 1 in 8 Americans Now Use for Weight Loss GLP-1 Medications: Everything You Need

Still, brand-name medications like Ozempic and Wegovy comprise 68% of current usage, according to Gallup, compared to 19% for compounded or custom-mixed versions of the medicine

While surgery still delivers the most extreme weight loss, the convenience and scalability of injectables may shift patient and physician preferences over time

doi: 10.1111/all.14879 [DOI] [PMC free article] [PubMed] [Google Scholar] 146

Nutrient deficiencies secondary to bariatric surgery

It is unclear how the duration and dosing used in this experimental system reflects the in vivo setting, though it would be of interest to benchmark the degree of desensitization/functional antagonism achieved in these studies to the GIPR antagonizing antibodies advancing through the clinic [5] or peptide antagonists reported in the literature [36]

Future research should aim to unravel the precise molecular mechanisms underlying these weight-independent benefits, enabling the development of new therapies that harness these anti-inflammatory pathways and potentially bypass the limitations of current interventions